Tech Company Financing Transactions

Fluxion Biosciences Funding Round

Fluxion Biosciences secured a $6.9 million Series B financing round on 11/9/2007. Investors included Claremont Creek Ventures, Kodiak Venture Partners and Life Science Angels.

Transaction Overview

Announced On
Transaction Type
Venture Equity
Series B
Proceeds Purpose
Proceeds purposes were not disclosed.

Company Information

Company Status
Private & Independent
Medical Devices & Instruments
Mailing Address
1600 Harbor Bay Pkwy. 150
Alameda, CA 94502
Email Address
Innovative microfluidics based tools for cellular analysis. Main Products: IsoFlux: Molecular analysis of circulating tumor cells (CTC). BioFlux: in vivo conditions for live cell analysis. IonFlux: Automated patch clamp system with continuous flow.
Fluxion Biosciences LinkedIn Company Profile
Social Media
Fluxion Biosciences Company Twitter Account
Company News
Fluxion Biosciences News
Fluxion Biosciences on Facebook
Fluxion Biosciences on YouTube

Management Team

Email & Social
Chief Executive Officer
Jeff Jensen
  Jeff Jensen LinkedIn Profile  Jeff Jensen Twitter Account  Jeff Jensen News  Jeff Jensen on Facebook
Chief Technical Officer
Cristian Zanetti
  Cristian Zanetti LinkedIn Profile  Cristian Zanetti Twitter Account  Cristian Zanetti News  Cristian Zanetti on Facebook
Vice President
Ali Yehia
  Ali Yehia LinkedIn Profile  Ali Yehia Twitter Account  Ali Yehia News  Ali Yehia on Facebook



Browse more venture capital transactions:

Prev: 11/9/2007: TAKKLE venture capital transaction
Next: 11/9/2007: JoMaJa venture capital transaction


Share this article


About Database of VC Transactions

We do our best to report on funding rounds that are announced publicly. VC investment data records reported here are sourced from news reports and company announcements. The data comes to us via our partnership with, an affiliated venture.


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities


Business Glossary